First European Phase Ii Trial of Intravenous (Iv) Cetuximab (Cet) and Hepatic Artery Infusion (Hai) of Irinotecan, 5-Fluorouracil and Oxaliplatin in Patients with Unresectable Liver Metastases from Wt Kras Colorectal Cancer (Crc) After Systemic Therapy Failure (Optiliv, Nct00852228)

AuthID
P-005-EWZ
18
Author(s)
Levi, F
·
Rougier, P
·
Focan, CNJ
·
Carvalho, C
·
Tumolo, S
·
Innominato, PF
·
Ajavon, Y
·
Castaing, D
·
De Baere, T
·
Karaboue, A
·
Lepere, C
·
Boige, V
·
Proux, L
·
Adam, R
·
Bouchahda, M
1
Group Author(s)
ARTBC Int
Document Type
Abstract
Year published
2012
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 30, Issue: 15
Conference
48Th Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: JUN 01-06, 2012, Location: Chicago, IL, Sponsors: Amer Soc Clin Oncol (ASCO)
Indexing
Publication Identifiers
Wos: WOS:000318009805028
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.